Previously, research on controlling gene networks has been carried out based on a single stimulus-response of cells. More recently, studies have been proposed to precisely analyze complex gene networks to identify control targets. A KAIST research team has succeeded in developing a universal technology that identifies gene control targets in altered cellular gene networks and restores them. This achievement is expected to be widely applied to new anticancer therapies such as cancer reversibility, drug development, precision medicine, and reprogramming for cell therapy.

Since its release last year, the open-source platform BindCraft, developed at EPFL, has already disrupted the world of protein design.

Cancer cells provide healthy neighbouring cells with additional cell powerhouses to put them to work. This has been demonstrated by researchers at ETH Zurich in a new study. In this way, cancer is exploiting a mechanism that frequently serves to repair damaged cells.

We’re thrilled to announce the launch of Biocontaminant, a multidisciplinary journal dedicated to tackling biocontamination and its impacts on sustainable development and global health. From pathogens and toxins to invasive species and antimicrobial resistance – this journal explores the critical challenges threatening our SDGs.

In Japan, emergency personnel are required to continue resuscitation efforts for cardiac arrest patients, even when there is no electrical activity. This is known as asystole. That policy has created an opportunity for scientists to assess how to treat the most difficult cases in resuscitation science. By analyzing outcomes from a large-scale national dataset, this study raises tough questions about the impact of pre-hospital life support procedures on outcomes in patients with asystole.